Authors:
Gales, AC
Jones, RN
Turnidge, J
Rennie, R
Ramphal, R
Citation: Ac. Gales et al., Characterization of Pseudomonas aeruginosa isolates: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999, CLIN INF D, 32, 2001, pp. S146-S155
Citation: Ma. Pfaller et al., Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program, CLIN INF D, 32, 2001, pp. S156-S167
Authors:
Livermore, DM
Carter, MW
Bagel, S
Wiedemann, B
Baquero, F
Loza, E
Endtz, HP
van den Braak, N
Fernandes, CJ
Fernandes, L
Frimodt-Moller, N
Rasmussen, LS
Giamarellou, H
Giamarellos-Bourboulis, E
Jarlier, V
Nguyen, J
Nord, CE
Struelens, MJ
Nonhoff, C
Turnidge, J
Bell, J
Zbinden, R
Pfister, S
Mixson, L
Shungu, DL
Citation: Dm. Livermore et al., In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia, ANTIM AG CH, 45(6), 2001, pp. 1860-1867
Authors:
Li, J
Turnidge, J
Milne, R
Nation, RL
Coulthard, K
Citation: J. Li et al., In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis, ANTIM AG CH, 45(3), 2001, pp. 781-785
Citation: J. Turnidge, Special issue: Urinary tract infection - Proceedings of the 5th International Symposium on Clinical Evaluation of Drug Efficacy in Urinary Tract Infection held 29 June 1997 in Sydney, Australia and of the Symposia 'Urinary Tract Infections' of the Commission for Treatment of Urinary Tract Infectionof the International Society of Chemotherapy held during the 20th International Congress of Chemotherapy - 29 June-3 July 1997 in Sydney, Australia -Opening remarks, INT J ANT A, 11(3-4), 1999, pp. VII-VII